FDA Disclaimer

Last updated: January 2026

About Dietary Supplements

Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), dietary supplements are regulated as a category of food rather than as drugs. This means:

• Manufacturers, not the FDA, are responsible for the safety and accurate labeling of dietary supplements.
• Supplements do not undergo the same approval process as prescription drugs.
• Supplements may not be marketed as a treatment or cure for any specific disease.
• The FDA can take action against unsafe supplements after they reach the market.

Structure and Function Claims

Statements on this Website regarding ingredients in Nitric Boost Ultra describe how those ingredients may support normal body functions — for example, supporting healthy circulation or supporting nitric oxide production. These are known as "structure and function" claims and are permitted under DSHEA when accompanied by the FDA disclaimer above. They are not claims to treat, prevent, or cure any disease.

Manufacturing Standards

Nitric Boost Ultra is manufactured in the United States in a facility that follows the FDA's Good Manufacturing Practice (GMP) regulations for dietary supplements (21 CFR Part 111). These regulations cover ingredient identity, purity, strength, composition, and contamination controls during production.

Individual Results

Results vary from person to person. The information on this Website, including testimonials and reviews, represents the experiences of specific individuals. Your experience may differ. Factors that influence results include consistency of use, baseline health status, diet, sleep, exercise, age, and individual biochemistry.

Consult Your Healthcare Provider

You should always consult a qualified healthcare provider before:

• Starting any new dietary supplement
• Combining a supplement with prescription or over-the-counter medication
• Beginning a supplement during pregnancy, breastfeeding, or before a planned surgical procedure
• Using a supplement to address any specific health concern

The information on this Website is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Drug Interaction Awareness

Ingredients in Nitric Boost Ultra influence vasodilation. Individuals taking the following classes of medication should consult a physician before use:

• Antihypertensive medications (blood pressure drugs)
• Nitrates (such as nitroglycerin)
• PDE5 inhibitors (such as sildenafil, tadalafil, and vardenafil)
• Anticoagulants and antiplatelet drugs (blood thinners)

Reporting Adverse Events

If you experience an adverse reaction to Nitric Boost Ultra, please discontinue use, consult your healthcare provider, and report the event to us at support@getnitricboost.com. You may also report serious adverse events directly to the FDA through the MedWatch program at fda.gov/safety/medwatch.

Contact